Advertisement

1H and 13C NMR Spectral Characteristics of 15-Substituted Pregn-5-Ene and Androst-5-Ene Steroid Compounds

  • A. V. BaranovskyEmail author
  • R. P. Litvinovskaya
Article

Two-dimensional NMR spectroscopy was used to assign the signals of the hydrogen and carbon atoms in the spectra of 15-substituted androstane and pregnane steroid compounds.

Keywords

androstanes pregnanes 15-substituted steroids NMR spectroscopy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. V. Baranovsky, R. P. Litvinovskaya, and V. A. Khripach, Zh. Org. Khim., 40, No. 11, 1656–1664 (2004).Google Scholar
  2. 2.
    A. V. Baranovsky, R. P. Litvinovskaya, and V. A. Khripach, Zh. Org. Khim., 43, No. 8, 1159–1164 (2007).Google Scholar
  3. 3.
    A. V. Baranovsky, M. P. Popova, and V. A. Khripach, Khim. Prirodn. Soedin., 51, No. 2, 254–259 (2015).Google Scholar
  4. 4.
    A. L. Gurskii, A. V. Baranovsky, P. Drashar, V. N. Zhabinskii, and V. A. Khripach, Dokl. Nats. Akad. Nauk Belarusi, 62, No. 2, 178–184 (2018).CrossRefGoogle Scholar
  5. 5.
    Y. Miyake, Y. Kubo, S. Iwabuchi, and M. Kojima, Steroids, 40, No. 3, 245–259 (1982).CrossRefGoogle Scholar
  6. 6.
    M. Linder, B. Desfosses, and R. Emiliozzi, Steroids, 29, No. 2, 161–170 (1977).CrossRefGoogle Scholar
  7. 7.
    D. C. Labaree, J. X. Zhang, H. A. Harris, C. O'Connor, T. Y. Reynolds, and R. B. Hochberg, J. Med. Chem., 46, No. 10, 1886–1904 (2003).CrossRefGoogle Scholar
  8. 8.
    D. Poirier, Y. Merand, C. Labrie, and F. Labrie, Bioorg. Med. Chem. Lett., 6, No. 21, 2537–2542 (1996).CrossRefGoogle Scholar
  9. 9.
    U. Kerb, Y. Nishino, and D. Henderson, 1-Methyl-15-Alkylandrosta-1,4-Diene-3,17-Diones, Process for Their Preparation and Pharmaceutical Compositions Containing Them, Pat. DE 3,539,244 A1 (1988).Google Scholar
  10. 10.
    U. Kerb, Y. Nishino, and D. Henderson, 1-Methyl-15-Alpha-(1,2-Dialkanoyloxyalkyl)Androsta-1,4-Diene-3,17-Diones. Process for Their Preparation and Pharmaceutical Compositions Containing Them, Pat. DE 3,703,722 A1 (1988).Google Scholar
  11. 11.
    U. Kerb, D. Nishino, and D. Henderson, 1-Methyl-15-Alpha-1-(Oxyalkyl)Androstane-1,4Diene-3,17-Diones, Process for Their Preparation and Pharmaceutical Compositions Containing Them, Pat. DE 3,705,990 A1 (1988).Google Scholar
  12. 12.
    R. Bohlmann, D. Henderson, U. Kerb, Y. Nishino, and G. Sauer, 4.15-Disubstituted 4-Androstene-3,17-Diones, and Process for Their Preparation, Pat. EP 0286578 A1 (1988).Google Scholar
  13. 13.
    J. Messinger, H. Thole, B. Husen, B. Van Steen, G. Schneider, J. B. E. Hulshof, P. Koskimies, N. Johansson, and J. Adamski, Novel 17β-Hydroxysteroid Dehydrogenase Type I Inhibitors, Pat. WO 2005047303 A2 (2005).Google Scholar
  14. 14.
    J. Messinger, H. Thole, B. Husen, M. Weske, P. Koskimies, and L Pirkkala, 17SS-HSDI and STS Inhibitors, Pat. US 2006281710 A1 (2006).Google Scholar
  15. 15.
    J. Messinger, U. Schoen, H. Thole, B. Husen, P. Koskimies, N. Kallio, and L. Pirkkala, Therapeutically Active Triazoles and Their Use, Pat. US 2008146531 A1 (2008).Google Scholar
  16. 16.
    J. Messinger, H. Thole, B. Husen, M. Weske, P. Koskimies, L. Pirkkala, and M. Weske, 17β-HSDI and STS Inhibitors, Pat. WO 2006125800 A1 (2006).Google Scholar
  17. 17.
    P. Dionne, B. T. Ngatcha, and D. Poirier, Steroids, 62, No. 10, 674–681 (1997).CrossRefGoogle Scholar
  18. 18.
    D. Poirier, Y. Merand, and F. Labrie, Tetrahedron, 47, No. 37, 7751–7766 (1991).CrossRefGoogle Scholar
  19. 19.
    J. W. Blunt and J. B. Strothers, Org. Magn. Resonance, No. 9, 439–464 (1977).Google Scholar
  20. 20.
    D. N. Kirk, H. C. Toms, C. Douglas, K. A. White, K. E. Smith, S. Latif, and R. W. P. Hubbard, J. Chem. Soc., Perkin Trans. 2, No. 9, 1567–1594 (1990).Google Scholar
  21. 21.
    J. D. Warthen, R. M. Waters, and J. E. Oliver, Spectrochim. Acta, A: Mol. Biomol. Spectrosc., 46A, No. 3, 369–375 (1990).ADSCrossRefGoogle Scholar
  22. 22.
    E. G Cherepanov and V. S. Bogdanov, Izv. Akad. Nauk SSSR, Ser. Khim., No. 10, 2234–2244 (1989).Google Scholar
  23. 23.
    M. Biesemans and G. Van de Woude, Bull. Soc. Chim. Belg., 92, No. 8, 731–741 (1983).CrossRefGoogle Scholar
  24. 24.
    T. Ibuka, T. Taga, T. Shingu, M. Saito, S. Nishii, and Y. Yamamoto, J. Org. Chem., 53, No. 17, 3947–3952 (1988).CrossRefGoogle Scholar
  25. 25.
    L. Castedo, J. R. Granja, and A. Mourino, Tetrahedron Lett., 26, No. 40, 4959–4960 (1985).CrossRefGoogle Scholar
  26. 26.
    A. D. Batcho, D. E. Berger, S. G. Davoust, P. M. Wovkulich, and M. R. Uskokovic, Helv. Chim. Acta, 64, No. 5, 1682–1687 (1981).CrossRefGoogle Scholar
  27. 27.
    I. Izzo. M. Di Filippo, R. Napolitano, and F. De Riccardis, Eur. J. Org. Chem., 64, No. 12, 3505–3510 (1999).CrossRefGoogle Scholar
  28. 28.
    G. Bojack and H. Kuenzer, Tetrahedron Lett., 35, No. 48, 9025–9026 (1994).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institute of Bioorganic ChemistryNational Academy of Sciences of BelarusMinskBelarus

Personalised recommendations